Trademark: 78962714
Word
ZELLETRA
Status
Dead
Status Code
606
Status Date
Monday, July 13, 2009
Serial Number
78962714
Mark Type
4000
Filing Date
Tuesday, August 29, 2006
Published for Opposition
Tuesday, January 16, 2007
Abandoned Date
Monday, July 13, 2009

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders, antipsychotic agents and antidepressants

Trademark Events
Jul 13, 2009
Abandonment Notice Mailed - No Use Statement Filed
Jul 13, 2009
Abandonment - No Use Statement Filed
Dec 12, 2008
Extension 2 Granted
Dec 3, 2008
Extension 2 Filed
Dec 12, 2008
Case Assigned To Intent To Use Paralegal
Dec 3, 2008
Teas Extension Received
Jun 4, 2008
Extension 1 Granted
May 29, 2008
Extension 1 Filed
May 29, 2008
Teas Extension Received
Dec 11, 2007
Noa Mailed - Sou Required From Applicant
Oct 30, 2007
Opposition Terminated No. 999999
Oct 30, 2007
Opposition Sustained No. 999999
Jul 16, 2007
Opposition Instituted No. 999999
Jan 24, 2007
Extension Of Time To Oppose Received
Jan 16, 2007
Published For Opposition
Dec 27, 2006
Notice Of Publication
Nov 27, 2006
Law Office Publication Review Completed
Nov 22, 2006
Assigned To Lie
Nov 14, 2006
Approved For Pub - Principal Register
Nov 13, 2006
Assigned To Examiner
Sep 6, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24